NASDAQ:MLTX

Moonlake Immunotherapeutics Stock Forecast

etoro logo Buy MLTX
*Your capital is at risk
$19.02
-0.340 (-1.76%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of MLTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MLTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Evaluation of MoonLake Immunotherapeutics stock downgraded after the last trading session
(Updated on Jul 24, 2026)

Sell candidate since Jul 24, 2026

The MoonLake Immunotherapeutics stock price fell by -1.76% on the last day (Friday, 24th Jul 2026) from $19.36 to $19.02. During the last trading day the stock fluctuated 3.45% from a day low at $18.82 to a day high of $19.47. The price has been going up and down for this period, and there has been a -6.58% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -92 thousand shares and in total, 651 thousand shares were bought and sold for approximately $12.38 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $18.69 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 15.59% during the next 3 months and, with a 90% probability hold a price between $21.61 and $26.99 at the end of this 3-month period.

MLTX Signals & Forecast

There are few to no technical positive signals at the moment. The MoonLake Immunotherapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $19.30 and $19.32. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -14.17%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for MoonLake Immunotherapeutics stock

MoonLake Immunotherapeutics finds support from accumulated volume at $18.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.650 (3.45%) between high and low. For the last week, the stock has had daily average volatility of 5.71%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MLTX) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect MoonLake Immunotherapeutics to open at $19.10, and during the day (based on 14 day Average True Range), to move between $18.50 and $19.54, which gives a possible trading interval of +/-$1.04 (+/-5.65%) up or down from last closing price. If MoonLake Immunotherapeutics takes out the full calculated possible swing range there will be an estimated 5.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $18.84 (0.95%) than the resistance at $20.00 (5.15%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MoonLake Immunotherapeutics stock A Buy?

The MoonLake Immunotherapeutics stock holds several negative signals and despite the positive trend, we believe MoonLake Immunotherapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -3.100 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $19.10 ( 0.438%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MLTX Performance

Trading levels for MLTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 19.75 3.86%
R2 19.51 2.55%
R1 19.35 1.74%
Price 19.02
S1 18.86 -0.87%
S2 18.70 -1.67%
S3 18.45 -2.98%

Accumulated Volume Support & Resistance Levels

Level Price
R3 22.16 16.51%
R2 20.36 7.05%
R1 20.00 5.15%
Price 19.02
S1 18.84 -0.95%
S2 18.41 -3.21%
S3 18.19 -4.36%

FAQ

What is the symbol for MoonLake Immunotherapeutics Stock and on which exchange is it traded?
The symbol for MoonLake Immunotherapeutics is MLTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MoonLake Immunotherapeutics Stock?
The MoonLake Immunotherapeutics stock holds several negative signals and despite the positive trend, we believe MoonLake Immunotherapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy MoonLake Immunotherapeutics Stock?
MoonLake Immunotherapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MoonLake Immunotherapeutics Stock.

What's the current price of MoonLake Immunotherapeutics Stock?
As of the end of day on the Jul 24, 2026, the price of an MoonLake Immunotherapeutics (MLTX) share was $19.02.

What is the 52-week high and low for MoonLake Immunotherapeutics Stock?
The 52-week high for MoonLake Immunotherapeutics Stock is $62.76 and the 52-week low is $5.95.

What is the market capitalization of MoonLake Immunotherapeutics Stock?
As of the Jul 24, 2026, the market capitalization of MoonLake Immunotherapeutics is 1.571B.

When is the next earnings date for MoonLake Immunotherapeutics?
The upcoming earnings date for MoonLake Immunotherapeutics is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT MOONLAKE IMMUNOTHERAPEUTICS
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE